University Hospitals Cleveland Medical Center
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, University Hospitals Cleveland Medical Center sits in the top decile of US sponsors by registered trial count (#142 of 15,742 sponsors by registered trial count).
University Hospitals Cleveland Medical Center: 230 sponsored US clinical trials, 42 recruiting.
University Hospitals Cleveland Medical Center sponsors 230 registered US clinical trials on ClinicalTrials.gov, 42 of them currently recruiting, and 154 completed. 48 of these trials are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bipolar Disorder, with 6 trials.
Top-decile sponsor footprint
University Hospitals Cleveland Medical Center ranks in the top decile of sponsors by registered trial count (#142 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
154 of 181 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
230 total, page 3 of 5
Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast
NCT03442088
Pain Management in Outpatient Urologic Procedures
NCT03393364
Hemoglobin Desaturation in Sickle Cell Disease
NCT03908385
Resourcefulness Intervention With Parents of Technology-Dependent Children
NCT03301831
Effect of Non-Dissection of the Inferior Rectus Sheath on Intraoperative Blood Loss
NCT02762773
The Effectiveness of Kuvan in Amish PKU Patients
NCT02677870
TRUST Study of Adolescent Weight Self-Management
NCT03016247
Safety of Immediate Skin-to-Skin Contact After Vaginal Birth in Vigorous Late-Preterm Neonates
NCT03585192
The Effect of Abdominal Binder Use on Postoperative Pain and Mobility in Patients Undergoing Pelvic Surgery
NCT03684304
Determining the Prognostic Value of Continuous Intrathecal Infusion
NCT03523000
Sickle Cell Disease, Hemechip
NCT03948516
BEATS 2: Music Therapy in Sickle Cell
NCT03233269
L-Menthol Injection as a Novel Technique During Colonoscopy
NCT02588248
Ice T Postoperative Multimodal Pain Regimen in FPMRS Surgery
NCT03052816
Efficacy of Buprenorphine on Postoperative Endodontic Analgesia
NCT03268278
Resourcefulness Training and Decentering on Self-Management in Caregivers of Technology Dependent Children
NCT02993887
Improving Value of Care for Patients With Severe Stasis Dermatitis
NCT03022786
Effect of Vitamin D After Application With Valchlor
NCT02968446
Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
NCT02872597
The Cleveland Cardiometabolic Cohort
NCT03059121
Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis
NCT02866721
The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders
NCT02804334
Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery
NCT02509312
Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain
NCT02886286
Feasibility Study of Couple Therapy Treatment for Situational Couple Violence
NCT03498638
Rostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder
NCT02655978
Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial
NCT02169089
Goal Achievement and Patient Satisfaction in Benign Hysterectomy
NCT02621710
Music Therapy in Sickle Cell Transition Study
NCT02466555
Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)
NCT02486367
Impact of Fitbit Plus Weight Management Program on Physical Activity and Metabolic Disease in Obese Adolescents
NCT02507791
Contraceptive Counseling in the Postpartum Period
NCT02380781
Sleep, Circadian Rhythm & Skin Health
NCT02457000
Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin
NCT03138252
Down Syndrome Memantine Follow-up Study
NCT02304302
Music Therapy in Sickle Cell Pain Mixed Methods Study
NCT02270060
Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain
NCT02173405
Use of EndoPAT for Measurements of Endothelial Dysfunction in HIV Infected Children and Healthy Controls
NCT02324179
Subsymptom Threshold Exercise Protocol Following Mild TBI
NCT02267668
A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness
NCT02085447
IL-17 Neutrophils in CF Lung Inflammation
NCT02025829
DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
NCT01982760
Nebulized Hypertonic Saline for Mechanically Ventilated Children
NCT01945944
Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid
NCT02343757
Laser Spot Treatment of Perioral Rhytids
NCT01986634
Effect of a One Time Dose of Cholecalciferol on Serum Concentration of 25-Hydroxyvitamin D and Macrophages
NCT02920502
Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery
NCT01866657
Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease
NCT01894594
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
NCT02330380
Infant Antibiotic Resistance and Implications for Therapeutic Decision-making
NCT01781182
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 13 |
| Phase 3 | 16 |
| Phase 4 | 32 |
Where University Hospitals Cleveland Medical Center enrollment is open (later-stage tilt)
42 recruiting of 230 indexed (18% open); 154 completed (67%).
Phase mix: 48 late (III/IV) vs 27 early (I/II) (later-stage heavy).
Top condition: Bipolar Disorder (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University Hospitals Cleveland Medical Center: open-pipeline peers nationwide
Peers matched on 230 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University Hospitals Cleveland Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 230 trials (± recruiting share)
- Brown University · 231 trials · 15% recruiting
- University of Iowa · 228 trials · 12% recruiting
- Georgetown University · 227 trials · 15% recruiting
- Henry Ford Health System · 234 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
- Imunon · 18% recruiting · 11 trials
- InventisBio Co. · 18% recruiting · 11 trials
Related
What to do with this University Hospitals Cleveland Medical Center page
230 registered trials is a research-attention snapshot, not an endorsement of University Hospitals Cleveland Medical Center or any single study.
- 42 of University Hospitals Cleveland Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bipolar Disorder is the condition University Hospitals Cleveland Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bipolar Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University Hospitals Cleveland Medical Center pipeline card: 230 registered trials from official public datasets.Report a data error.